Search for: "State of West Virginia v. Pfizer, Inc." Results 21 - 30 of 30
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Dec 2014, 5:00 am
                  Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
9 Apr 2015, 5:00 am
  Finally, as we’ve blogged about before, West Virginia federal courts have recently cut back Karl to drug DTC advertising cases. [read post]
17 Dec 2009, 11:22 am
This decision invoked "forum public policy" to apply West Virginia's rejection of the learned intermediary rule to a forum shopping plaintiff from Alabama - a staunch learned intermediary state. [read post]
28 Oct 2011, 7:00 am by Bexis
Pfizer, Inc., 358 F.3d 659, 661 (9th Cir. 2004) (“the doctor who prescribed [the drug] . . . failed to read [the defendant’s] published warnings before prescribing the drug. [read post]
7 Jan 2010, 10:36 am by Beck, et al.
In some other places (Mississippi, West Virginia), counsel turned to mass filings to evade restrictions on class actions.And for just as long, federal courts have held that polyglot complaints of this nature violate the permissive joinder requirements of Rule 20. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]